Nitric oxide - A newly discovered chemical transmitter in human skin

British Journal of Dermatology

Volumn 137, Issue 5, 1997, Pages 665-672

  Weller, R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIUM DERIVED RELAXING FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; ECZEMA; ENZYME LOCALIZATION; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; RAT; REVIEW; SKIN INFECTION; SKIN INFLAMMATION; SKIN NECROSIS; WOUND HEALING;

EID: 0030695384     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb01099.x     Document Type: Review

References (68)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
2. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
3. Anggard E. Nitric oxide: mediator, murderer, and medicine [see comments]. Lancet 1994; 343: 1199-206.
4. Knowles RG, Moncada S. Nitric oxide synthases in mammals [Review]. Biochem J 1994; 298: 249-58.
5. Dippel E, Mayer B, Schonfelder G et al. Distribution of constitutive nitric oxide synthase immunoreactivity and NADPH-diaphorase activity in murine telogen and anagen skin. J Invest Dermatol 1994; 103: 112-15.
6. Bull HA, Hothersall J, Chowdhury N et al. Neuropeptides induce release of nitric oxide from human dermal microvascular endothelial cells. J Invest Dermatol 1996; 106: 655-60.
7. Shimizu Y, Sakai M, Umemura Y et al. Expression of endothelial nitric oxide synthase in human eccrine clear cells. Br J Dermatol 1997; 136: 572-4.
8. Sakai M, Shimizu Y, Nagazu I et al. Immunohistochemical localization of NO synthases in normal human skin and psoriatic skin. Arch Dermatol Res 1996; 288: 625-7.
9. Sirsjo A, Karlsson M, Gidlof A et al. Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes. Br J Dermatol 1996; 134: 643-8.
10. Qureshi AA, Hosoi J, Xu S et al. Langerhans cells express inducible nitric oxide synthase and produce nitric oxide. J Invest Dermatol 1996; 107: 815-21.
11. Cho HJ, Xie Q, Calaycay J et al. Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 1992; 176: 599.
12. Liew FY. Regulation of nitric oxide synthesis in infectious and autoimmune diseases [Review]. Immunol Lett 1994; 43: 95-8.
13. Lincoln TM, Komalavilas P, Boerth NJ et al. cGMP signaling through cAMP- and cGMP-dependent protein kinases. In: Nitric Oxide, Biochemistry, Molecular Biology and Therapeutic Implications (Ignarro L, Murad F, eds). San Diego: Academic Press, Inc., 1995; 305-22.
14. Stuehr DJ, Nathan CF. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumour target cells. J Exp Med 1989; 169: 1543-5.
15. Kwon NS, Stuehr DJ, Nathan CF. Inhibition of tumour cell ribonucleotide reductase by macrophage-derived nitric oxide. J Exp Med 1991; 174: 761-7.
16. + channel in cultured human dermal papilla cells. J Invest Dermatol 1996; 106: 342-5.
17. Darley-Usmar V, Wiseman H, Halliwell B. Nitric oxide and oxygen radicals: a question of balance [Review]. FEBS Lett 1995; 369: 131-5.
18. Abrahamsson T, Brandt U, Marklund SL et al. Vascular bound recombinant extracellular superoxide dismutase type C protects against the detrimental effects of superoxide radicals on endothelium-dependent arterial relaxation. Circ Res 1992; 70: 264-71.
19. Benjamin N, O'Driscoll F, Dougall H et al. Stomach NO synthesis. Nature 1994; 368: 502.
20. Tannenbaum SR, Weisman M, Fett D. The effect of nitrate intake on nitrite content in human saliva. Food Cosmet Toxicol 1976; 14: 549-52.
21. Duncan C, Dougall H, Johnston P et al. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nature Med 1995; 1: 546-51.
22. Deliconstantinos G, Villiotou V, Stravrides JC. Release by ultraviolet B (u.v.B) radiation of nitric oxide (NO) from human keratinocytes: a potential role for nitric oxide in erythema production. Br J Pharmacol 1995; 114: 1257-65.
23. Weller R, Pattullo S, Smith L et al. Nitric oxide is generated on the skin surface by reduction of sweat nitrate. J Invest Dermatol 1996; 107: 327-31.
24. Springall DR, Riveros-Moreno V, Buttery L et al. Immunological detection of nitric oxide synthase(s) in human tissues using heterologous antibodies suggesting different isoforms. Histochemistry 1992; 98: 259-66.
25. Goldsmith PC, Leslie TA, Hayes NA et al. Inhibitors of nitric oxide synthase in human skin. J Invest Dermatol 1996; 106: 113-18.
26. Lawrence E, Brain SD. Responses to endothelins in the rat cutaneous microvasculature: a modulatory role of locally produced nitric oxide. Br J Pharmacol 1992; 106: 733-8.
27. Benrath J, Zimmermann M, Gillardon F. Substance P and nitric oxide mediate wound healing of ultraviolet photodamaged rat skin: evidence for an effect of nitric oxide on keratinocyte proliferation. Neurosci Lett 1995; 200: 17-20.
28. Stadler J, Stefanovic-Racic M, Billiar T et al. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 1991; 147: 3915-20.
29. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leucocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-5.
30. Morris SM, Billiar TR. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 1994; 266: E829-39.
31. Griffiths CE. Cutaneous leukocyte trafficking and psoriasis [editorial]. Arch Dermatol 1994; 130: 494-9.
32. Schlaak JF, Buslau M, Jochum W et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994; 102: 145-9.
33. Baker BS, Fry L. The immunology of psoriasis. Br J Dermatol 1992; 126: 1-9.
34. Ormerod A, Benjamin N, Herriot R et al. Inducible nitric oxide is upregulated in psoriasis. Clin Exp Dermatol 1995; 20: 277-8.
35. Kolb-Bachofen V, Fehsel K, Michel G et al. Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of psoriasis vulgaris. Lancet 1994; 344: 139.
36. Rowe A, Farrell A, Kazmi SH et al. Expression of inducible nitric oxide synthase in dermal microvasculature in psoriasis [letter; comment]. Lancet 1994; 344: 1371.
37. Lemster BH, Carroll PB, Rilo HR et al. IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy. Clin Exp Immunol 1995; 99: 148-54.
38. Bruch-Gerharz D, Fehsel K, Suschek C et al. A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med 1996; 184 2007-12.
39. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
40. Weller R, Ormerod A, Benjamin N. Nitric oxide generation measured directly from psoriatic plaques by chemiluminescence. Br J Dermatol 1996; 134: 569.
41. Norris DA. Differential control of cell death in the skin. Arch Dermatol 1995; 131: 945-8.
42. Messmer UK, Ankarcrona M, Nicotera P et al. p53 expression in nitric oxide-induced apoptosis. FEBS Lett 1994; 355: 23-6.
43. Blanco FJ, Ochs RL, Schwarz H et al. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995; 146: 75-85.
44. Mannick JB, Asano K, Izumi K et al. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 1994; 79: 1137-46.
45. Heck DE, Laskin DL, Gardner CR et al. Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J Biol Chem 1992; 267: 21277-80.
46. Schopf RE, Welke F, Dobmeyer T et al. Apoptosis of epidermal cells in psoriatic plaques is decreased. J Invest Dermatol 1995; 104: 610.
47. Warren JB, Loi RK, Coughlan ML. Involvement of nitric oxide synthase in the delayed vasodilator response to ultraviolet light irradiation of rat skin in vivo. Br J Pharmacol 1993; 109: 802-6.
48. Warren JB. Nitric oxide and human skin blood flow responses to acetylcholine and ultraviolet light. FASEB J 1994; 8: 247-51.
49. Cavallo J, Deleo VA. Sunburn. Dermatol Clin 1986; 4: 181-7.
50. Deliconstantinos G, Villiotou V, Stavrides JC. Alterations of nitric oxide synthase and xanthine oxidase activities of human keratinocytes by ultraviolet B radiation. Biochem Pharmacol 1996; 51: 1727-38.
51. Mancinelli RL, McKay CP. Effects of nitric oxide and nitrogen dioxide on bacterial growth. Appl Env Microbiol 1983; 46: 198-202.
52. Klebanoff SJ. Reactive nitrogen intermediates and antimicrobial activity: role of nitrite. Free Radical Biol Med 1993; 14: 351-60.
53. Cenci E, Romani L, Mencacci A et al. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol 1993; 23: 1034-8.
54. Jones-Carson J, Vazquez-Torres A, van der Heyde HC et al. Gamma delta T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nature Med 1995; 1: 552-7.
55. Adams LB, Franzblau SG, Vavrin Z et al. L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. J Immunol 1991; 147: 1642-6.
56. Liew FY, Li Y, Moss D et al. Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur J Immunol 1991; 21: 3009-14.
57. Wei XQ, Charles IG, Smith A et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995; 375: 408-11.
58. Dykhuizen RS, Frazer R, Duncan C et al. Antimicrobial effect of acidified nitrite on gut pathogens: importance of dietary nitrate in host defense. Antimicrobial Agents Chemother 1996; 40: 1422-5.
59. Weller R, Hobson R, Ormerod AD et al. Acidified nitrite cream is an effective treatment for tinea pedis. Br J Dermatol 1996; 135 (Suppl. 47): 21.
60. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-6.
61. Weller R, Dykhuizen R, Leifert C et al. Nitric oxide release accounts for the reduced incidence of cutaneous infections in psoriasis. J Am Acad Dermatol 1997; 36: 281-2.
62. Liew FY. Regulation of lymphocyte functions by nitric oxide [Review]. Curr Opin Immunol 1995; 7: 396-9.
63. Taylor-Robinson AW, Liew FY, Severn A et al. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur J Immunol 1994; 24: 980-4.
64. Sicher SC, Vazquez MA, Lu CY. Inhibition of macrophage Ia expression by nitric oxide. J Immunol 1994; 153: 1293-300.
65. Rowe A, Farrell AM, Bunker CB. Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. Br J Dermatol 1997; 136: 18-23.
66. Dwyer CD, Ormerod AD. Inducible NOS expression in allergic and irritant dermatitis. J Invest Dermatol 1995; 105: 481.
67. Morita H, Hori M, Kitano Y. Modulation of picryl chloride-induced contact hypersensitivity reaction in mice by nitric oxide. J Invest Dermatol 1996; 107: 549-52.
68. Morris CJ, Earl JR, Trenam CW et al. Reactive oxygen species and iron - a dangerous partnership in inflammation. Int J Biochem Cell Biol 1995; 27: 109-22.